Clinical Trial Update: Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating gemcitabine with or without nab-paclitaxel in elderly pancreatic cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Adenocarcinoma Pancreas | Phase 4 | Status: COMPLETED